This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
While most white matter (WM) demyelinating lesions in multiple sclerosis (MS) have a perivascular distribution, heterogeneity in lesion pathology has been shown to include a variable relationship between lesions and parenchymal blood vessels.1 Reports that such lesion characteristics at brain biopsy predict treatment response suggest that identifying perivascular lesions in vivo could be clinically relevant.2 It is unclear, however, to what extent the age and topographic location of a lesion influence its vascular anatomy.
This pilot study aimed to develop an imaging technique capable of defining the relationship between demyelination and small parenchymal blood vessels in MS. Comparison between T2-weighted MR images at 1.5 tesla with subsequent venography has previously been used to determine the relationship of lesions to blood vessels.3 While this technique can demonstrate an MS lesion and a blood vessel in close proximity, the inability to demonstrate both structures simultaneously means the exact spatial relationship cannot be defined or followed longitudinally. Ultra-high field human MRI offers an increased signal to noise ratio and enhanced spatial resolution compared to clinical MRI scanners, at the expense of increased radiofrequency and static field inhomogeneity which result in a (smooth) variation of intensity across the image and distortions at structural boundaries. T2* contrast observed at ultra high field strengths …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham